Journals / TSK Koruyucu Hekimlik Bülteni / 2011 / Cilt: 10 - Sayı: 4

Kadınlarda Metabolik Sendrom: Bursa Türkiye’de Yapılan Bir Çalışma

Metabolic Syndrome among Women: A Study from Bursa Turkey

Pages
421–432
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: In conclusion it can be stated that obesity and central obesity are alarmingly frequent among the adult Turkish women who participated in our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Obesity is one of the risk factors of metabolic syndrome (MetS) and its prevalence is rapidly increasing in Turkey.
📊
Key Findings & Data:The purpose of this study was to assess the prevalence of MetS and obesity among women aged 20 years and older.
💡
Conclusion & Impact:CONCLUSION: In conclusion it can be stated that obesity and central obesity are alarmingly frequent among the adult Turkish women who participated in our study.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

AIM: Obesity is one of the risk factors of metabolic syndrome (MetS) and its prevalence is rapidly increasing in Turkey. The purpose of this study was to assess the prevalence of MetS and obesity among women aged 20 years and older. METHOD: This is a cross- sectional study, undergone in a primary health care setting in Bursa /Turkey in the year 2008. A total of 807 women were included in the study. Body weight, height, waist circumference, blood pressure, total and HDL cholesterol, fasting plasma glucose and triglyceride levels were measured. Metabolic Syndrome definition was made according to the International Diabetes Federation (IDF) criteria. RESULTS: The mean age was 42.7±13.2 years, 96.4% were married, 50.7% had education of less than 8 years, 93.7% were housewives and 85.3% had a monthly family income of $650 or less. The prevalence of MetS and abdominal obesity were 17.5% and 87.7% respectively. Those with diabetes mellitus and elevated plasma lipids had increased risk of developing MetS 11.3 and 4.5 times more than those without these situations respectively. The risk of MetS increases with age and increasing BMI. CONCLUSION: In conclusion it can be stated that obesity and central obesity are alarmingly frequent among the adult Turkish women who participated in our study. Despite the high prevalence of elevated waist circumference and body mass index the low prevalence of MetS could not be explained. The low levels of triglycerides and high levels of high density lipoprotein cholesterol should be studied further. Because of its cross-sectional and single center oriented design the results of this study should not be generalized

Özet

AMAÇ: Obezite metabolik sendromdaki risk faktörlerinden biridir ve Türkiye'deki prevalansı giderek artmaktadır. Bu çalışmanın amacı 20 yaş ve üzeri kadınlarda metabolik sendrom ve obezite sıklığını araştırmaktır. YÖNTEM: Kesitsel bir çalışmadır. Bursa'da birinci basamak sağlık hizmeti veren bir kuruluşta 2008 yılında yapılmıştır. Toplam 807 kadın çalışmaya alınmıştır. Katılımcıların ağırlık, boy, bel çevresi, kan basıncı, toplam ve HDL kolesterol, açlık kan şekeri ve trigliserid düzeyleri ölçülmüştür. Metabolik sendrom tanısı Uluslararası Diabet Federasyonu kriterlerine göre konulmuştur. BULGULAR: Katılımcıların yaş ortalaması 42,7±13,2'dir. Yüzde 96,4'ü evlidir. Yüzde 50,7'sinin eğitim düzeyi 8 yılın altındadır. Yüzde 93,7'si ev kadınıdır ve %85,3'ünün aylık aile geliri 650$ veya altındadır. Metabolik sendrom ve abdominal obezite prevalansı sırasıyla %17,5 ve %87,7 olarak bulunmuştur. Diyabeti ve yüksek kan yağlarına sahip olanlarda metabolik sendrom oluşma riski sırasıyla 11,3 ve 4,5 kez daha fazladır. Metabolik sendrom görülme riski yaşla ve vücut kitle indeksinin artmasıyla artmaktadır. SONUÇ: Çalışmamıza katılan kadınlarda obezite ve abdominal obezitenin yaygın olduğu saptanmıştır. Bel çevresi uzunluğundaki ve vücut kitle indeksindeki artışa rağmen metabolik sendrom prevalansının düşük bir düzeyde oluşu açıklanamamıştır. Trigliserid düzeyindeki düşüklük ve yüksek dansiteli lipoprotein kolesterol düzeyindeki yükseklik konularının daha ileri biçimde araştırılması gerekir. Kesitsel ve tek bir merkezde yapılan bir çalışma olması nedeniyle bu çalışmanın sonuçları genelleştirilmemelidir

🔖

Cite This Article

ORHAN, H., SADIKOĞLU, G., ÖZÇAKIR, A., BİLGEL, N. G. (2011). Kadınlarda Metabolik Sendrom: Bursa Türkiye’de Yapılan Bir Çalışma. TSK Koruyucu Hekimlik Bülteni, Cilt: 10 - Sayı: 4, 421–432. https://ajindex.com/articles/129196

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. 1 Timar O, Sestier F, Levy E. Metabolic Syndrome X: a review. Can J Cardiol. 2000
  2. 2 Lindberg O, Tilvis RS, Strandberg TE, et al. Impacts of components of the metabolic syndrome on health status and survival in an aged population. Eur J Epidemiol. 1997
  3. 3 WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva, WHO, 1999. 4 Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group fort he study of Insulin Resistance (EGIR). Diabet Med. 1999
  4. 5 NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA. 2001
  5. 6 Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003
  6. 7 Alberti KM, Zimmet P, Shaw J. The metabolic syndrome- a new worldwide definition. Lancet. 2005
  7. 8 Assmann G, Guerra R, Fox G, et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007
  8. 9 Ford ES. Prevalence of the metabolic syndrome defined by the Interanational Diabetes Federation among adults in the U.S. Diabetes Care. 2005
  9. 10 Choi KM, Kim SM, Kim YE, Choi DS, Baik SH. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Educating Program and International Diabetes Federation definitions in the Korean population. Metabolism. 2007
  10. 11 Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract. 2007
  11. 12 Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest. 2007
  12. 13 Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Educating Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005
  13. 2588a- 2589. 14 Sanisoglu Y, Oktenli C, Hasimi A, Yokusoglu M, Ugurl